CALGARY, AB, April 23, 2024 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), – Canadabis Capital, and its shareholdings in Stigma Grow a leading innovator in the Canadian cannabis industry, is thrilled to announce the launch of the latest addition to the Dab Bods brand lineup – a ground breaking 60%+ double-infused pre-roll. This new offering sets a new benchmark for THC potency in the Canadian market, catering to cannabis enthusiasts seeking a premium, high-potency experience.

VANCOUVER, BC, April 1, 2024 /CNW/ - Trading resumes in:

CALGARY, AB, April 1, 2024 /CNW/ - At the request of CIRO, CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.

Gross quarterly revenue of $7.1 million Fiscal Q2/24 marks tenth consecutive quarter generating positive net income Adjusted EBITDA1 in fiscal Q2/24 of $0.6 millionOver 2000% growth in net revenue from Cultivation & Wholesale segmentCALGARY, AB, April 1, 2024 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce results from our second quarter fiscal 2024, represented by our tenth consecutive quarter generating net revenue. The Company's Financial Statements and Notes, as well as Manag

VANCOUVER, BC, April 1, 2024 /CNW/ - The following issues have been halted by CIRO

Gross quarterly revenue of $9 million is 18% higher than the previous quarter and 15% higher than the same period in 2023Fiscal Q1/24 marks ninth consecutive quarter generating positive net income and earnings per shareAdjusted EBITDA1 in fiscal Q1/24 exceeded $1.1 million, a 16% increase over fiscal Q1/23CALGARY, AB, Jan. 2, 2024 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce our first quarter fiscal 2024 results featuring another consecutive period of growth in gross and net reven

Positive fiscal 2023 net income of $4.4 million grew 631% over fiscal 2022 and drove annual earnings per share of $0.03Gross revenue totaled $34.6 million for the full year, expanding 103% over 2022Net revenue in 2023 of $22.2 million grew 90% over 2022, while 2023 gross profit increased 111% to $11.8 millionAdjusted EBITDA1 expanded to $5.8 million in 2023, reflecting growth of 238% year-over-year and increased 161% to $1.8 million in Q4/23CALGARY, AB, Nov. 29, 2023 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis

CALGARY, AB, Oct. 25, 2023 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is proud to announce a landmark achievement with subsidiary Stigma Grow being the recipient of Grow Up Industry's coveted 2023 Product of the Year award for Dab Bods' Phoenix Tears ("Phoenix Tears"). We extend heartfelt congratulations to our dedicated employees at Stigma Grow, whose continued hard work and ongoing commitment to excellence have culminated in this award. We are also pleased to share an update on the Company's anticip

CALGARY, AB, Aug. 31, 2023 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB) a premium vertically integrated Canadian cannabis company, is pleased to report that at our Annual & Special Meeting (the "Meeting") held on August 30, 2023, all resolutions proposed to shareholders were duly passed.

Recorded earnings per share for the third consecutive quarter and a seventh consecutive quarter generating positive net incomeNet income increased 874% in Q3/23 and 2,431% in the nine month period relative to 2022Gross revenue of $9.6 million grew 123% in Q3/23 and for the nine months YTD was 154% higher at $27.0 million vs 2022 Net revenue of $6.1 million increased 111% while gross profit rose 113% to $2.7 million in Q3/23 vs Q3/22Adjusted EBITDA1 of $1.5 million in Q3/23 increased 226% year-over-year and was in-line with the previous quarterCALGARY, AB, June 29, 2023 /CNW/ - CanadaBis Capi

CALGARY, AB, June 19, 2023 /CNW/ - Canadabis Capital Inc. ("CanadaBis" or "the Company"), a leading Canadian cannabis company, is excited to announce the launch of its new super slim style pre roll line. The company aims to provide its consumers with a wide range of premium quality products, and believes that the new line will cater to those looking for a more sophisticated smoking experience.

CALGARY, AB, June 1, 2023 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company") is pleased to announce that Nicole Bacsalmasi, LL.B has joined the Board of Directors and has been appointed as a member of the Audit Committee.

Positive earnings per share for the second consecutive quarter and fifth consecutive quarter generating net incomeNet income grew 373% over the same period in 2022Gross revenue in Q2/23 was the highest since inception at $9.6 million, and grew 23% over Q1/23Net revenue grew 124% to a record $6.2 million, while gross profit increased 120% in fiscal Q2/23 compared to the same period in 2022Record Adjusted EBITDA1 totaled $1.6 million, an increase of 175% year-over-yearCALGARY, AB, April 3, 2023 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically int

VANCOUVER, BC / ACCESSWIRE / February 6, 2023 / The Power Play by The Market Herald has announced the release of new interviews with CanadaBis Capital, Callinex Mines and Datametrex AI discussing their latest news.

CALGARY, AB, Jan. 24, 2023 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium and vertically-integrated Canadian cannabis company, is pleased to provide an update for shareholders on the considerable progress made in significantly expanding and enhancing our reach, market share and financial position over the past year, as well as provide insights into the pipeline of future opportunities made possible by our  financial performance over the past four quarters.

Fiscal Q1/23 marks our fifth consecutive quarter generating net income and first quarter with positive earnings per share.Net income increased by 292% compared to the same period in 2022Gross quarterly revenue of $7.8 million was the highest since inception and 22% higher than the previous quarterYear-over-year net revenue grew 178% to $5.1 million while gross profit increased 154% to $2.4 millionAdjusted EBITDA1 was a record $967,178 for Q1/23, increasing 43% over the previous quarterCALGARY, AB, Dec. 30 2022 /CNW/ - CanadaBis Capital Inc. with its wholly owned sub Stigma Grow (the "Company

Fiscal 2022 featured four consecutive quarters of positive net income and significant year-over-year earnings growthGross revenue of $17.1 million and gross profit of $5.6 million are highest in company history Strong momentum exiting Q4/22 lends visibility into continued revenue, gross profit and earnings expansion through Q1/23 and beyondCALGARY, AB, Nov. 29, 2022 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB) along with its subsidiaries STIGMA GROW AND INDICATIVE COLLECTION, a premium vertically integrated Canadian cannabis company, is very pleased to announce

Fiscal 2022 featured four consecutive quarters of positive net income and significant year-over-year earnings growthGross revenue of $17.1 million and gross profit of $5.6 million are highest in company history Strong momentum exiting Q4/22 lends visibility into continued revenue, gross profit and earnings expansion through Q1/23 and beyondCALGARY, AB, Nov. 29, 2022 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB) along with its subsidiaries STIGMA GROW AND INCICATIVE COLLECTION, a premium vertically integrated Canadian cannabis company, is very pleased to announce

CALGARY, AB, June 23, 2022 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB) a premium vertically integrated Canadian cannabis company, is pleased to announce record fiscal Q3 2022 financial results for the three and nine-month period ending April 30, 2022.

CALGARY, AB, June 23, 2022 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB.V) a premium vertically integrated Canadian cannabis company, is pleased to report that at our Annual & Special Meeting (the "Meeting") held on June 23, 2022, all resolutions proposed to shareholders were duly passed.

CALGARY, AB, March 30, 2022 /CNW/ - CanadaBis Capital (the "Company" or "CanadaBis Capital") (TSXV: CANB.V) a premium cannabis and concentrates producer, is pleased to announce its Second Quarter Fiscal 2022 financial results for the three month period ending January 31, 2022.

Red Deer, Alberta--(Newsfile Corp. - December 1, 2021) - CanadaBis Capital Inc. (TSXV: CANB) ("CanadaBis" or "the Company") with its subsidiary Stigma Grow, is a Canadian cannabis concentrates company focused on capitalizing growth and diversification opportunities. The Company is proud to report certain operational updates.

Red Deer, Alberta--(Newsfile Corp. - November 3, 2021) - CanadaBis Capital Inc. (TSXV: CANB) (the "Corporation" or "CanadaBis")  announced today that it has made the decision to withdraw its previously announced short-form prospectus offering of units (the "Public Offering").

Red Deer, Alberta--(Newsfile Corp. - September 7, 2021) - CanadaBis Capital Inc. (TSXV: CANB) (the "Corporation" or "CanadaBis") is pleased to announce that, further to its press release on June 2, 2021, the first tranche of funding of $7,210,000 in respect of the previously announced new credit facility (the "New Credit Facility") with Connect First Credit Union Ltd. (the "Lender") was completed on July 23, 2021. The New Credit Facility is comprised of (i) a five-year term secured loan of $8,850,000 (the "Loan") bearing interest at a fixed rate of 4.35% per annum (calculated daily and payable monthly in arrears); and (ii) a $750,000 demand line of credit bearing interest at a rate of the Lender's prime lending rate plus 1.00% per annum (calculated daily and payable monthly in arrears). The proceeds of the Loan will be used to refinance outstanding debt. The funds from the demand line will be used to assist with day-to-day operations, as required. The second tranche of funding ($1,640,000) shall be advanced by the Lender upon completion and delivery of the Corporation's July 31, 2021 year-end audited financials, provided all financial covenants and benchmarks have been met or exceeded.

Fresh off the heels of the launch of several new SKUs across Canada, CanadaBis Capital Inc. is quickly emerging as a recognized and respected name in BHO concentrates

Red Deer, Alberta--(Newsfile Corp. - June 2, 2021) - CanadaBis Capital Inc. (TSXV: CANB) ("CanadaBis" or the "Company") is pleased to announce that it has filed with, and obtained a receipt for, a preliminary short form prospectus dated June 1, 2021 (the "Prospectus") with respect to a marketed offering (the "Offering") of units (the "Units") of the Company for gross proceeds to the Company of up to $5,000,000 at a price to be determined in the context of the market. Each Unit will consist of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"), with each Warrant being exercisable to acquire one Common Share.

RED DEER, AB, April 6, 2021 /CNW/ - Stigma Grow ("Stigma" or the "Company") and its parent company, CanadaBis Capital Inc. (TSXV: CANB), are thrilled to announce they have entered into a third-party production agreement (the "Agreement") with Sundial Growers Inc. (NASDAQ: SNDL) ("Sundial" or the "Company"), a Health Canada licensed cannabis producer recognized for its 'small-batch-at-scale' individualized 'room' approach, to produce a variety of Sundial's hydrocarbon (BHO) concentrates.

Partnership sees launch of BevCanna products under Stigma Grow's Sales License across Canada

/NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

CALGARY, AB / ACCESSWIRE / February 26, 2021 / CanadaBis Capital Inc. ("CanadaBis" or "the Company") has granted options to employees and consultants under its Stock Option Plan, to purchase up to 1,050,000 common shares for a period of five years commencing on February 26, 2021 at an exercise price of $0.20 per share. The options will vest one-half immediately and the remaining half shall vest one year from the date of grant.

TSX-V: CANB

Alberta, Canada, Jan. 21, 2021 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company") with its subsidiary Stigma Grow, is a vertically integrated Canadian cannabis company focused on capitalizing growth and diversification opportunities.  The Company is proud to report certain operational updates.

Stigma Grow's new licences allow for the direct sale of cannabis extracts, including their expanding lineups of shatter, live resin vape cartridges, budders, waxes and more.

RED DEER, AB, Dec. 7, 2020 /CNW/ - CANADABIS CAPITAL, (STIGMA GROW), (INDICAtive Collection), a National pioneer in cannabis concentrate production, research, cultivation and distribution, reports financial results for the fourth quarter and full fiscal year ended July 31, 2020. All financial information in this press release is reported in CAD dollars, unless otherwise indicated.

CALGARY, AB / ACCESSWIRE / October 27, 2020 / This press release is being disseminated as required by National Instrument 62-103 -The Early Warning System and Take over Bid and Insider Reporting Issues regarding the disposition and acquisition of securities of CanadaBis Capital Inc. ("CanadaBis").

RED DEER, AB, Oct. 14, 2020 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company") is a vertically integrated Canadian cannabis company focused on capitalizing future growth and diversification opportunities.  The Company is pleased to announce several updates from its subsidiary Stigma Grow ("1998643 AB LTD.") including new, in-demand full-spectrum product lines and an advantageous new partnership that ensures product availability across Canada.

CALGARY, AB / ACCESSWIRE / September 14, 2020 / This press release is being disseminated as required by National Instrument 62-103 - The Early Warning System and Take over Bid and Insider Reporting Issues regarding the disposition and acquisition of securities of CanadaBis Capital Inc. ("CanadaBis").

RED DEER, AB / ACCESSWIRE / September 14, 2020 / CanadaBis Capital Inc. ("CanadaBis" or the "Company") is pleased to announce that it has closed a non-brokered private placement for 3,583,333 shares ( Common Shares ) at a price of $0.15 per Common Share for gross proceeds of up to $537,499.95.

RED DEER, AB / ACCESSWIRE / August 31, 2020 / CanadaBis Capital Inc. (TSXV:CANB) ("CanadaBis" or the "Company") is pleased to announce a non-brokered private placement of up to 3,666,666 shares ( Common Shares ) at a price of $0.15 per Common Share for gross proceeds of up to $550,000.

CALGARY, AB / ACCESSWIRE / July 31, 2020 / CanadaBis Capital Inc. (TSXV:CANB) ("CanadaBis" or "the Company") has granted options to its directors and officers under its Stock Option Plan, to purchase up to 4,550,000 common shares for a period of five years commencing on July 31st, 2020 at an exercise price of $0.20 per share. The options will vest one-half immediately and the remaining half shall vest one year from the date of grant.

In a market saturated with unattractive pre-rolls made with mid-potency and blended shake — high-potency, bud-run pre-rolls have a very bright future.

As they continue to grow, Stigma Grow is already producing large quantities of both live resin and cured concentrates for in-house and third-party cannabis brands.

RED DEER, AB / ACCESSWIRE / April 30, 2020 / CanadaBis Capital Inc. ("CanadaBis" or the "Company") is pleased to announce that it has closed a non-brokered private placement for 8,295,993 shares ( Common Shares ) at a price of $0.15 per Common Share for gross proceeds of up to $1,244,398.95.

RED DEER, AB / ACCESSWIRE / April 20, 2020 / CanadaBis Capital Inc. ("CanadaBis" or the "Company") is pleased to announce a non-brokered private placement of up to 10,000,000 shares ( Common Shares ) at a price of $0.15 per Common Share for gross proceeds of up to $1,500,000.

CALGARY, AB / ACCESSWIRE / April 15, 2020 / This press release is being disseminated as required by National Instrument 62-103 - The Early Warning System and Take over Bid and Insider Reporting Issues regarding the disposition and acquisition of securities of CanadaBis Capital Inc. ("CanadaBis").

CALGARY, AB / ACCESSWIRE / April 15, 2020 / This press release is being disseminated as required by National Instrument 62-103 - The Early Warning System and Take over Bid and Insider Reporting Issues regarding the disposition and acquisition of securities of CanadaBis Capital Inc. ("CanadaBis").

RED DEER, AB, March 10, 2020 /CNW/ - CanadaBis Capital Inc. (TSX-V: CANB) ("CanadaBis" or "the Company") a holder of a federal licence to cultivate and process under the Cannabis Act, is pleased to announce that on March 6th, 2020, its subsidiary 1998643 AB LTD. ("Stigma Grow") secured its licence from Health Canada to sell cannabis cultivated at its 66,000 square foot cultivation facility in Red Deer, Alberta.

CALGARY, Feb. 11, 2020 /CNW/ - CanadaBis Capital Inc. (TSX-V:CANB) ("CanadaBis" or "the Company") a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act, has announced its strategic direction and facility expansion focus for its subsidiary 1998643 AB LTD. ("Stigma Grow")

CALGARY, AB / ACCESSWIRE / November 29, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "the Company"), announces today that Shawn Ryan, Chief Financial Officer (CFO), has resigned to pursue other opportunities effective November 28, 2019.

Lotions and balms are the first of many unique Stigma Roots lifestyle products boasting a wide-range of health and wellness benefits

RED DEER, AB / ACCESSWIRE / October 22, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "the Company"), through its subsidiary 1998643 Alberta Ltd. ("Stigma Grow"), is pleased to announce that it has successfully executed its option to purchase its leased cultivation facility, located in Red Deer County, Alberta.

One of Alberta's up-and-coming cannabis brands is now poised to influence four pillars of industry: cultivation, processing, lifestyle and retail.

TSX-V: CANBwww.canadabis.com

TSX-V: CANBwww.canadabis.com

CALGARY, AB / ACCESSWIRE / August 2, 2019 / CanadaBis Capital Inc. (“CanadaBis” or “the Company”) announced on July 24, 2019, the acquisition of Full Spectrum Labs Ltd., a private corporation which holds intellectual property (IP) and the physical equipment for an extraction methodology to preserve all of the phytocannabinoids and terpenes from cannabis by utilizing an extreme low-temperature process to create the Company’s future concentrates. CanadaBis wishes to clarify the news release by adding that the Agreement is also subject to an Earned out Payment of $

TSX-V: CANBwww.canadabis.com

TSX-V: CANBwww.canadabis.com

CALGARY, AB / ACCESSWIRE / July 15, 2019 / CanadaBis Capital Inc. (“CanadaBis” or “the Company”), a licensed cannabis producer under the Cannabis Act, is pleased to announce that it has completed its second cannabis harvest and has submitted dried samples for analytical testing. Upon completion of analytical testing, CanadaBis will amend its existing Health Canada sales license to include dried flower and oils.

CALGARY, AB / ACCESSWIRE / July 2, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "the Company") has entered into an agreement to acquire all the outstanding shares of 2103157 Alberta Ltd. operating as Indicative Collection (the "Acquiree"), which holds a cannabis retail store development license in Red Deer, Alberta. Located in the heart of Gasoline Alley, this storefront will face one of Alberta's busiest avenues and provide easy access to travelers passing through the Red Deer hub.

CALGARY, AB / ACCESSWIRE / May 27, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "The Company") through its wholly owned subsidiary Stigma Grow ("Stigma") is proud to launch a new partnership in education with Olds College.

CALGARY, AB / ACCESSWIRE / May 13, 2019 / CanadaBis Capital Inc. ("CanadaBis" or the "Company") is proud to announce that its solely owned subsidiary Stigma Grow ("Stigma") has completed harvest number one under the Health Canada Cultivation License. Stigma's first crop produced an ultra-premium, quality crop with great terpene profiles. This crop will be used as test crop "one" of the two required for their sales application process. Stigma is midway through cultivation of the second crop using another of its proven genetics and anticip

CALGARY, AB / ACCESSWIRE / April 30, 2019 / CanadaBis Capital Inc.("CanadaBis or the Company") is pleased to announce that it will begin trading as a Tier 2 Life Sciences Issuer on April 30th, 2019 under the symbol CANB and that it has officially launched its new corporate website, which is now available at www.canadabis.com.

VANCOUVER, April 29, 2019 /CNW/ - Trading resumes in:

CALGARY, AB / ACCESSWIRE / April 26, 2019 / CanadaBis Capital Inc. (CANB.P: TSX-V) is pleased to announce that it has completed its previously announced qualifying transaction (the "Transaction") with 1926360 Alberta Ltd. dba Stigma Pharmaceuticals ("Stigma"). The Transaction constitutes a "Qualifying Transaction" as such term is defined by Policy 2.4 of the TSX Venture Exchange (the "TSXV") Corporate Finance Manual and was completed by way of three corner amalgamation pursuant to which

CALGARY, AB / ACCESSWIRE / April 18, 2019 / CanadaBis Capital Inc. "TSX-V: CANB.P" ("CanadaBis" or the "Company"), an Alberta capital pool corporation listed on the TSX Venture Exchange, is pleased to announce that it has received conditional acceptance from the TSX Venture Exchange ("TSXV") for its proposed qualifying transaction (the "Qualifying Transaction") with 1926360 Alberta Ltd. doing business as Stigma Pharmaceuticals

CALGARY, AB / ACCESSWIRE / March 21, 2019 / CanadaBis Capital Inc. "TSXV: CANB.P" ("CanadaBis" or the "Company"), an Alberta capital pool corporation listed on the TSX Venture Exchange, and 1926360 Alberta Ltd. doing business as Stigma Pharmaceuticals ("Stigma"), a recreational and medical cannabis and cannabis products company with a facility located in Red Deer, Alberta, are pleased to announce they are in the final stages of completin

Pursuant to the Amalgamation Agreement, the parties thereto will effect a "three-cornered" amalgamation whereby 2146541 Alberta Ltd. (a wholly-owned subsidiary of CanadaBis) and Stigma will amalgamate with holders of Stigma each receiving one common share of CanadaBis ("CanadaBis Share"), for every common share in Stigma held (the "Transaction"). The Transaction is expected to constitute a Qualifying Transaction of CanadaBis pursuant to TSXV Policy 2.4 Capital Pool Companies, subject to Exchange approval, and upon completion there

Calgary, Alberta (FSCwire) - CANADABIS CAPITAL INC. (TSXV - CANB.P) (the “Corporation”), a capital pool company, is pleased to announce that it has signed a letter of intent dated July 19, 2018, (the "LOI") with 1926360 Alberta Ltd., dba Stigma Pharmaceuticals, a private Alberta company specializing in the growth and marketing of medical cannabis and cannabis products ("Stigma").  The LOI outlines the general terms and conditions pursuant to which the Corporation and Stigma would be willing to complete a transaction that will result in a reverse take-over of the Corporation by the security holders of Stigma and is intended to constitute the “qualifying transaction” of the Corporation under Policy 2.4 – Capital Pool Companies of the TSX Venture Exchange (the "TSXV"). The Corporation expects to be classified as a Life Sciences issuer upon completion of the transaction.

VANCOUVER, July 20, 2018 /CNW/ - The following issues have been halted by IIROC:

VANCOUVER, April 12, 2018 /CNW/ - Trading resumes in:

CALGARY, Alberta, March 28, 2018 (GLOBE NEWSWIRE) -- CANADABIS CAPITAL INC. (TSXV:CANB.P) (the “Corporation”), a capital pool company, announces that further to its press releases dated January 19, 2018 and March 2, 2018, the letter of intent dated...

CALGARY, Alberta, March 02, 2018 (GLOBE NEWSWIRE) -- CANADABIS CAPITAL INC. (TSXV - CANB.P) (the “Corporation”), a capital pool company, announces that further to its press release dated January 19, 2018, the terms of the letter of intent...

Calgary, Alberta (FSCwire) - CANADABIS CAPITAL INC. (TSXV - CANB.P) (the “Corporation”), a capital pool company, is pleased to announce that it has signed a letter of intent dated January 19, 2018, (the "LOI") with Applied Data Finance, LLC, a limited liability company existing under the laws of the State of Delaware ("ADF").  The LOI outlines the general terms and conditions pursuant to which the Corporation and ADF would be willing to complete a transaction that will result in a reverse take-over of the Corporation by the security holders of ADF and is intended to constitute the “qualifying transaction” of the Corporation under Policy 2.4 – Capital Pool Companies of the TSX Venture Exchange (the "TSXV"). The Corporation expects to be classified as a Technology issuer upon completion of the transaction.

Vancouver, British Columbia--(Newsfile Corp. - January 15, 2018) - The following issues have been halted by IIROC:

VANCOUVER, Jan. 15, 2018 /CNW/ - The following issues have been halted by IIROC:

CANADABIS CAPITAL INC. (the "Corporation" or "CanadaBis") (TSX VENTURE: CANB.P), a capital pool company, announced today that it has changed its year-end to December 31st from November 30. CanadaBis' transition year will be the thirteen month period ending December 31, 2017. The new financial year will be the 13 month period ending December 31, 2017. This will align the Corporation's financial reporting with the majority of publicly traded companies and facilitate the process of completing a Qualifying Transaction pursuant to TSX Venture Exchange Policy 2.4.

CANADABIS CAPITAL INC. (the "Corporation" or "CanadaBis") (TSX VENTURE:CANB.P), a capital pool company, announced today that it has changed its year‐end to December 31st from November 30. CanadaBis' transition year will be the thirteen...

CANADABIS CAPITAL INC. (the "Corporation" or "CanadaBis") (TSX VENTURE: CANB.P), a capital pool company, is pleased to announce that it has completed its initial public offering of 5,000,000 common shares at the price of $0.10 per common share for gross proceeds of $500,000 and has filed for listing as a Capital Pool Company on the TSX Venture Exchange. Richardson GMP Limited (the "Agent") acted as agent on the offering. The common shares of CanadaBis are expected to commence trading on the TSX Venture Exchange ("TSXV") on or about March 10, 2017 under

CANADABIS CAPITAL INC. (the "Corporation" or "CanadaBis") (TSX VENTURE:CANB.P), a capital pool company, is pleased to announce that it has completed its initial public offering of 5,000,000 common shares at the price of $0.10 per common share for...